These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10344480)

  • 1. Objective non-invasive assessment of patch tests with the laser Doppler perfusion scanning technique.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 1999 May; 40(5):251-60. PubMed ID: 10344480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between laser Doppler perfusion imaging and visual scoring of patch test sites in subjects with experimentally induced allergic and irritant contact reactions.
    Goon AT; Leow YH; Chan YH; Goh CL
    Skin Res Technol; 2004 Feb; 10(1):64-6. PubMed ID: 14731251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of budesonide patch tests.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 1999 Oct; 41(4):211-7. PubMed ID: 10515100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dark test-substance pigmentation on skin perfusion assessments and effect of test technique on balsam of Peru patch-test results.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 2000 Jun; 42(6):318-25. PubMed ID: 10871094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of nickel sulfate patch test reactions with laser Doppler perfusion imaging.
    Bjarnason B; Fischer T
    Contact Dermatitis; 1998 Sep; 39(3):112-8. PubMed ID: 9771983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of test techniques of perfusion of neomycin sulfate patch tests. A comparative study with visual assessments.
    Bjarnason B; Flosadóttir E
    Contact Dermatitis; 2000 Nov; 43(5):283-94. PubMed ID: 11016670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual and laser Doppler perfusion scanning assessments of Kathon CG patch test reactions.
    Bjarnason B; Fischer T
    Am J Contact Dermat; 1998 Dec; 9(4):224-30. PubMed ID: 9810023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Contact Dermatitis; 1999 Jan; 40(1):24-31. PubMed ID: 9928801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of patch-test application tape on reactions to sodium dodecyl sulfate.
    Fischer T; Dahlén A; Bjarnason B
    Contact Dermatitis; 1999 Jan; 40(1):32-7. PubMed ID: 9928802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stronger patch test elicitation reaction to the allergen hydroxycitronellal plus the irritant sodium lauryl sulfate.
    Heydorn S; Andersen KE; Johansen JD; Menné T
    Contact Dermatitis; 2003 Sep; 49(3):133-9. PubMed ID: 14678209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of balsam of Peru patch tests.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 2000 Jun; 42(6):326-9. PubMed ID: 10871095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch testing with budesonide.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1998 Jul; 39(1):52-3. PubMed ID: 9686997
    [No Abstract]   [Full Text] [Related]  

  • 13. Noninvasive in vivo confocal laser scanning microscopy is effective in differentiating allergic from nonallergic equivocal patch test reactions.
    Slodownik D; Levi A; Lapidoth M; Ingber A; Horev L; Enk CD
    Lasers Med Sci; 2015 Apr; 30(3):1081-7. PubMed ID: 25604734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Diepgen T; Ducomb G; Frosch PJ; Goossens A; Lahti A; Menné T; Seidenari S; Tosti A; Wahlberg J; Wilkinson JD
    Contact Dermatitis; 2000 Jun; 42(6):352-4. PubMed ID: 10871102
    [No Abstract]   [Full Text] [Related]  

  • 15. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance.
    Färm G
    Acta Derm Venereol Suppl (Stockh); 1998; 201():1-42. PubMed ID: 9833065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity at edges of corticosteroid patch tests may be an indicator of a strong positive test response.
    Bjarnason B; Flosadóttir E; Fischer T
    Dermatology; 1999; 199(2):130-4. PubMed ID: 10559578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site variations in patch test responses on the back.
    van Strien GA; Korstanje MJ
    Contact Dermatitis; 1994 Aug; 31(2):95-6. PubMed ID: 7750276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low yield for extended reading of patch tests with topical corticosteroids.
    Davis MD; Richardson DM; Farmer SA
    Dermatitis; 2005 Sep; 16(3):124-6. PubMed ID: 16242083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 20. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.